Osteoclasts are essential for TNF-alpha-mediated joint destruction
Standard
Osteoclasts are essential for TNF-alpha-mediated joint destruction. / Redlich, Kurt; Hayer, Silvia; Ricci, Romeo; David, Jean-Pierre; Tohidast-Akrad, Makiyeh; Kollias, George; Steiner, Günter; Smolen, Josef S; Wagner, Erwin F; Schett, Georg.
In: J CLIN INVEST, Vol. 110, No. 10, 01.11.2002, p. 1419-27.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Osteoclasts are essential for TNF-alpha-mediated joint destruction
AU - Redlich, Kurt
AU - Hayer, Silvia
AU - Ricci, Romeo
AU - David, Jean-Pierre
AU - Tohidast-Akrad, Makiyeh
AU - Kollias, George
AU - Steiner, Günter
AU - Smolen, Josef S
AU - Wagner, Erwin F
AU - Schett, Georg
PY - 2002/11/1
Y1 - 2002/11/1
N2 - The detailed cellular and molecular mechanisms leading to joint destruction in rheumatoid arthritis, a disease driven by proinflammatory cytokines, are still unknown. To address the question of whether osteoclasts play a pivotal role in this process, transgenic mice that express human TNF (hTNFtg) and that develop a severe and destructive arthritis were crossed with osteopetrotic, c-fos-deficient mice (c-fos(-/-)) completely lacking osteoclasts. The resulting mutant mice (c-fos(-/-)hTNFtg) developed a TNF-dependent arthritis in the absence of osteoclasts. All clinical features of arthritis, such as paw swelling and reduction of grip strength, progressed equally in both groups. Histological evaluation of joint sections revealed no difference in the extent of synovial inflammation, its cellular composition (except for the lack of osteoclasts), and the expression of matrix metalloprotein-ase-3 (MMP-3) and MMP-13. In addition, cartilage damage, proteoglycan loss, and MMP-3, -9, and -13 expression in chondrocytes were similar in hTNFtg and c-fos(-/-)hTNFtg mice. However, despite the presence of severe inflammatory changes, c-fos(-/-)hTNFtg mice were fully protected against bone destruction. These data reveal that TNF-dependent bone erosion is mediated by osteoclasts and that the absence of osteoclasts alters TNF-mediated arthritis from a destructive to a nondestructive arthritis. Therefore, in addition to the use of anti-inflammatory therapies, osteoclast inhibition could be beneficial for the treatment of rheumatoid arthritis.
AB - The detailed cellular and molecular mechanisms leading to joint destruction in rheumatoid arthritis, a disease driven by proinflammatory cytokines, are still unknown. To address the question of whether osteoclasts play a pivotal role in this process, transgenic mice that express human TNF (hTNFtg) and that develop a severe and destructive arthritis were crossed with osteopetrotic, c-fos-deficient mice (c-fos(-/-)) completely lacking osteoclasts. The resulting mutant mice (c-fos(-/-)hTNFtg) developed a TNF-dependent arthritis in the absence of osteoclasts. All clinical features of arthritis, such as paw swelling and reduction of grip strength, progressed equally in both groups. Histological evaluation of joint sections revealed no difference in the extent of synovial inflammation, its cellular composition (except for the lack of osteoclasts), and the expression of matrix metalloprotein-ase-3 (MMP-3) and MMP-13. In addition, cartilage damage, proteoglycan loss, and MMP-3, -9, and -13 expression in chondrocytes were similar in hTNFtg and c-fos(-/-)hTNFtg mice. However, despite the presence of severe inflammatory changes, c-fos(-/-)hTNFtg mice were fully protected against bone destruction. These data reveal that TNF-dependent bone erosion is mediated by osteoclasts and that the absence of osteoclasts alters TNF-mediated arthritis from a destructive to a nondestructive arthritis. Therefore, in addition to the use of anti-inflammatory therapies, osteoclast inhibition could be beneficial for the treatment of rheumatoid arthritis.
KW - Animals
KW - Arthritis, Rheumatoid
KW - Carrier Proteins
KW - Collagenases
KW - Genes, fos
KW - Humans
KW - Matrix Metalloproteinase 13
KW - Matrix Metalloproteinase 3
KW - Matrix Metalloproteinase 9
KW - Membrane Glycoproteins
KW - Mice
KW - Mice, Inbred C57BL
KW - Mice, Knockout
KW - Mice, Transgenic
KW - Osteoclasts
KW - Osteopetrosis
KW - RANK Ligand
KW - Receptor Activator of Nuclear Factor-kappa B
KW - Tumor Necrosis Factor-alpha
U2 - 10.1172/JCI15582
DO - 10.1172/JCI15582
M3 - SCORING: Journal article
C2 - 12438440
VL - 110
SP - 1419
EP - 1427
JO - J CLIN INVEST
JF - J CLIN INVEST
SN - 0021-9738
IS - 10
ER -